血液凝固检验市场规模、份额、成长分析、按产品、按测试类型、按技术、按最终用户 - 行业预测，2024-2031 年

2022年全球血液凝固检验市场规模为27.4亿美元，预测期内（2024-2031年）复合年增长率为11.40%，从2023年的30.5亿美元增至2031年的72.4亿美元。美元。

受多种因素影响，全球血液凝固检验市场近年来持续成长。在心血管疾病、血液疾病和老年人口不断增加的推动下，血液凝固检查在诊断和监测与凝血相关的各种医疗状况方面发挥着重要作用。此外，血友病和血管性血友病等血液疾病的盛行率不断增加，大大推动了对血液凝固检验的需求。此外，外科手术和创伤的增加进一步增加了对准确、及时的凝血诊断的需求。然而，诊断产品和设备的严格监管要求正在影响新参与企业进入市场，因此遵守品质标准和监管核准对于市场参与企业至关重要。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场危机与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 成功的关键因素
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

依产品分类：血液凝固检验市场

• 市场概况
• 分析设备
• 消耗品

按测试类型：血液凝固检验市场

• 市场概况
• 凝血酶原时间
• 活化部份凝血活酵素时间
• D-二聚体测试
• 纤维蛋白原测试
• 其他（凝血酶时间、血小板功能检查）

依技术分：血液凝固检验市场

• 市场概况
• 光凝
• 机械混凝
• 电化学混凝

依最终用户分类：血液凝固检验市场

• 市场概况
• 医院
• 临床实验室
• 居家照护环境
• 就地检验

按地区划分：血液凝固检验市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Abbott Laboratories
• Siemens Healthcare
• Roche Diagnostics
• Beckman Coulter
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Stago
• Werfen
• DiaSys
• Cardinal Health
• Helena Laboratories
• Instrumentation Laboratory
• Diagnostica Stago
• Hyphen Biomed
• Alere Inc.
• CoaguSense
• Hemosonics
• Diagon
• ILine Microsystems
• Bio-Rad Laboratories

Global Coagulation Testing Market size was valued at USD 2.74 billion in 2022 and is poised to grow from USD 3.05 billion in 2023 to USD 7.24 billion by 2031, at a CAGR of 11.40% during the forecast period (2024-2031).

The global Coagulation Testing Market has experienced consistent growth recently, driven by various factors. Coagulation testing plays a crucial role in diagnosing and monitoring various medical conditions related to blood clotting, propelled by the increasing incidence of cardiovascular diseases, blood disorders, and a growing elderly population. Furthermore, the rise in the prevalence of blood disorders like hemophilia and von Willebrand disease has significantly fueled the demand for coagulation testing. Moreover, an increase in surgical procedures and trauma cases has further heightened the necessity for accurate and timely coagulation diagnostics. However, stringent regulatory requirements for diagnostic products and devices impact the market entry of new players, making compliance with quality standards and regulatory approvals essential for market participants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Testing Market Segmental Analysis

The global coagulation testing market is segmented into product, test type, technology, end-user, and region. Based on product, the market is segmented into analyzer and consumables. Based on type, the market is segmented into Prothrombin Time, Activated Partial Thromboplastin Time, D-dimer Testing, Fibrinogen Testing, Others (Thrombin Time, Platelet Function Tests). Based on Technology, the market is segmented into optical coagulation, mechanical coagulation, electrochemical coagulation. Based on end-user, the market is segmented into, Hospitals, clinical laboratories, home care settings, point-of-care testing. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Drivers of the Global Coagulation Testing Market

The rising incidence of cardiovascular diseases, alongside a worldwide population that is aging, highlights the escalating need for coagulation testing as a vital diagnostic measure. Furthermore, improvements in diagnostic technology, such as optical and electrochemical coagulation testing methods, bolster the precision and speed of results, fostering their uptake across various healthcare environments.

Restraints in the Global Coagulation Testing Market

One of the main obstacles in the marketplace stems from the challenges of standardizing coagulation testing procedures, particularly due to variations in results among different laboratories and settings. These inconsistencies can create hurdles for healthcare professionals in accurately interpreting results, potentially compromising the overall reliability of coagulation testing.

Market Trends of the Global Coagulation Testing Market

The noticeable transition to factor-of-care coagulation testing is propelled by the demand for swift diagnostic solutions in emergency scenarios and outpatient settings. This shift is driven by the necessity for rapid decision-making and is bolstered by technological advancements enabling the creation of portable, user-friendly coagulation testing devices, thereby enhancing their integration across diverse healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Coagulation Testing Market by Product

• Market Overview
• Analyzer
• Consumables

Coagulation Testing Market by Test Type

• Market Overview
• Prothrombin Time
• Activated Partial Thromboplastin Time
• D-dimer Testing
• Fibrinogen Testing
• Others (Thrombin Time, Platelet Function Tests)

Coagulation Testing Market by Technology

• Market Overview
• Optical Coagulation
• Mechanical Coagulation
• Electrochemical Coagulation

Coagulation Testing Market by End-user

• Market Overview
• Hospitals
• Clinical Laboratories
• Home Care Settings
• Point-of-Care Testing

Coagulation Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hyphen Biomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CoaguSense
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemosonics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ILine Microsystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments